Winner Profile
Dr. Hans-George Feldmeier
CEO, Dermapharm
Industry: Pharmaceuticals
Company size: Large
Published: 2020-07-27
Is Dermapharm a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Dr. Hans-George Feldmeier (Dermapharm) earned the following Obermatt pins for the management performance.
Obermatt accolades Dr. Hans-George Feldmeier
| Year | Pin | Category |
|---|---|---|
| 2020 |  |
Investment Performance |
 |
Combined Performance | |
|
Growth Performance | |
 |
Operating Performance |
Dr. Hans-George Feldmeier was included in the competition among Mid-sized Companies (Germany) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Dr. Hans-George Feldmeier
In summary, Dr. Hans-George Feldmeier obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 82 in Combined Performance indicates that Dr. Hans-George Feldmeier was better than 82% of all other CEOs that were analyzed as part of the Mid-sized Companies – Germany for one participation in Obermatt CEO competitions. Dr. Hans-George Feldmeier’s average ranking can be found in the Multi-Year Rankings for Mid-sized Companies - Germany.